Summary
Further key aspects of the report:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Chronic Idiopathic Constipation Drugs market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market for @@@@@ are the significant development of demand and improvement of COVID-19 and geo-economics.
Based on the type of product, the global Chronic Idiopathic Constipation Drugs market segmented into
Linaclotide
Lubiprostone
Others
Based on the end-use, the global Chronic Idiopathic Constipation Drugs market classified into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Based on geography, the global Chronic Idiopathic Constipation Drugs market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Pfizer
Glaxosmithkline
Roche Holding AG
Sanofi
Bayer AG
Merck
Eli Lilly
Allergens
Chugai Pharmaceutical
Ferring International Center S.A
Synergy Pharmaceuticals
Salix Pharmaceuticals Ltd
Sucampo Pharmaceuticals Inc
Ironwood Pharmaceuticals Inc
Valeant Pharmaceuticals International
Daiichi Sankyo
Cosmo Pharmaceuticals SA
Progenics Pharmaceuticals Inc
Theravance Biopharma Inc
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL CHRONIC IDIOPATHIC CONSTIPATION DRUGS INDUSTRY
2.1 Summary about Chronic Idiopathic Constipation Drugs Industry
2.2 Chronic Idiopathic Constipation Drugs Market Trends
2.2.1 Chronic Idiopathic Constipation Drugs Production & Consumption Trends
2.2.2 Chronic Idiopathic Constipation Drugs Demand Structure Trends
2.3 Chronic Idiopathic Constipation Drugs Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Linaclotide
4.2.2 Lubiprostone
4.2.3 Others
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 Hospital Pharmacies
4.3.2 Retail Pharmacies
4.3.3 Online Pharmacies
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Linaclotide
5.2.2 Lubiprostone
5.2.3 Others
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Online Pharmacies
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Linaclotide
6.2.2 Lubiprostone
6.2.3 Others
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 Hospital Pharmacies
6.3.2 Retail Pharmacies
6.3.3 Online Pharmacies
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Linaclotide
7.2.2 Lubiprostone
7.2.3 Others
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 Hospital Pharmacies
7.3.2 Retail Pharmacies
7.3.3 Online Pharmacies
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Linaclotide
8.2.2 Lubiprostone
8.2.3 Others
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 Hospital Pharmacies
8.3.2 Retail Pharmacies
8.3.3 Online Pharmacies
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Linaclotide
9.2.2 Lubiprostone
9.2.3 Others
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 Hospital Pharmacies
9.3.2 Retail Pharmacies
9.3.3 Online Pharmacies
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Pfizer
10.1.2 Glaxosmithkline
10.1.3 Roche Holding AG
10.1.4 Sanofi
10.1.5 Bayer AG
10.1.6 Merck
10.1.7 Eli Lilly
10.1.8 Allergens
10.1.9 Chugai Pharmaceutical
10.1.10 Ferring International Center S.A
10.1.11 Synergy Pharmaceuticals
10.1.12 Salix Pharmaceuticals Ltd
10.1.13 Sucampo Pharmaceuticals Inc
10.1.14 Ironwood Pharmaceuticals Inc
10.1.15 Valeant Pharmaceuticals International
10.1.16 Daiichi Sankyo
10.1.17 Cosmo Pharmaceuticals SA
10.1.18 Progenics Pharmaceuticals Inc
10.1.19 Theravance Biopharma Inc
10.2 Chronic Idiopathic Constipation Drugs Sales Date of Major Players (2017-2020e)
10.2.1 Pfizer
10.2.2 Glaxosmithkline
10.2.3 Roche Holding AG
10.2.4 Sanofi
10.2.5 Bayer AG
10.2.6 Merck
10.2.7 Eli Lilly
10.2.8 Allergens
10.2.9 Chugai Pharmaceutical
10.2.10 Ferring International Center S.A
10.2.11 Synergy Pharmaceuticals
10.2.12 Salix Pharmaceuticals Ltd
10.2.13 Sucampo Pharmaceuticals Inc
10.2.14 Ironwood Pharmaceuticals Inc
10.2.15 Valeant Pharmaceuticals International
10.2.16 Daiichi Sankyo
10.2.17 Cosmo Pharmaceuticals SA
10.2.18 Progenics Pharmaceuticals Inc
10.2.19 Theravance Biopharma Inc
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
Table Chronic Idiopathic Constipation Drugs Product Type Overview
Table Chronic Idiopathic Constipation Drugs Product Type Market Share List
Table Chronic Idiopathic Constipation Drugs Product Type of Major Players
Table Brief Introduction of Pfizer
Table Brief Introduction of Glaxosmithkline
Table Brief Introduction of Roche Holding AG
Table Brief Introduction of Sanofi
Table Brief Introduction of Bayer AG
Table Brief Introduction of Merck
Table Brief Introduction of Eli Lilly
Table Brief Introduction of Allergens
Table Brief Introduction of Chugai Pharmaceutical
Table Brief Introduction of Ferring International Center S.A
Table Brief Introduction of Synergy Pharmaceuticals
Table Brief Introduction of Salix Pharmaceuticals Ltd
Table Brief Introduction of Sucampo Pharmaceuticals Inc
Table Brief Introduction of Ironwood Pharmaceuticals Inc
Table Brief Introduction of Valeant Pharmaceuticals International
Table Brief Introduction of Daiichi Sankyo
Table Brief Introduction of Cosmo Pharmaceuticals SA
Table Brief Introduction of Progenics Pharmaceuticals Inc
Table Brief Introduction of Theravance Biopharma Inc
Table Products & Services of Pfizer
Table Products & Services of Glaxosmithkline
Table Products & Services of Roche Holding AG
Table Products & Services of Sanofi
Table Products & Services of Bayer AG
Table Products & Services of Merck
Table Products & Services of Eli Lilly
Table Products & Services of Allergens
Table Products & Services of Chugai Pharmaceutical
Table Products & Services of Ferring International Center S.A
Table Products & Services of Synergy Pharmaceuticals
Table Products & Services of Salix Pharmaceuticals Ltd
Table Products & Services of Sucampo Pharmaceuticals Inc
Table Products & Services of Ironwood Pharmaceuticals Inc
Table Products & Services of Valeant Pharmaceuticals International
Table Products & Services of Daiichi Sankyo
Table Products & Services of Cosmo Pharmaceuticals SA
Table Products & Services of Progenics Pharmaceuticals Inc
Table Products & Services of Theravance Biopharma Inc
Table Market Distribution of Major Players
Table Global Major Players Sales Revenue (Million USD) 2017-2020e
Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
Table Global Chronic Idiopathic Constipation Drugs Market Forecast (Million USD) by Region 2021f-2026f
Table Global Chronic Idiopathic Constipation Drugs Market Forecast (Million USD) Share by Region 2021f-2026f
Table Global Chronic Idiopathic Constipation Drugs Market Forecast (Million USD) by Demand 2021f-2026f
Table Global Chronic Idiopathic Constipation Drugs Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
Figure Global Chronic Idiopathic Constipation Drugs Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation Drugs Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation Drugs Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation Drugs Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
Figure Global Chronic Idiopathic Constipation Drugs Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Idiopathic Constipation Drugs Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
Figure Global Chronic Idiopathic Constipation Drugs Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Linaclotide Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Lubiprostone Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Others Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Hospital Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Retail Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Online Pharmacies Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Pfizer 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Glaxosmithkline 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Roche Holding AG 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Sanofi 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Bayer AG 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Merck 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Eli Lilly 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Allergens 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Chugai Pharmaceutical 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Ferring International Center S.A 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Synergy Pharmaceuticals 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Salix Pharmaceuticals Ltd 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Sucampo Pharmaceuticals Inc 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Ironwood Pharmaceuticals Inc 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Valeant Pharmaceuticals International 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Daiichi Sankyo 2017-2020e
Figure Chronic Idiopathic Constipation Drugs Sales Revenue (Million USD) of Cosmo Pharmaceuticals SA 2017-2020e
Figure Sales Revenue (Million USD) of Progenics Pharmaceuticals Inc 2017-2020e
Figure Sales Revenue (Million USD) of Theravance Biopharma Inc 2017-2020e